FOGPHARMA Trademark

Trademark Overview


On Thursday, November 14, 2019, a trademark application was filed for FOGPHARMA with the United States Patent and Trademark Office. The USPTO has given the FOGPHARMA trademark a serial number of 88692445. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by Fog Pharmaceuticals, Inc.. The FOGPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development in the field of biotechnology and pharmaceuticals; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields
fogpharma

General Information


Serial Number88692445
Word MarkFOGPHARMA
Filing DateThursday, November 14, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6241168
Registration DateTuesday, January 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements


Pseudo MarkFOG PHARMA
Goods and ServicesScientific research and development in the field of biotechnology and pharmaceuticals; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2019
Primary Code042
First Use Anywhere DateWednesday, August 24, 2016
First Use In Commerce DateWednesday, August 24, 2016

Trademark Owner History


Party NamePARABILIS MEDICINES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Monday, November 18, 2019NEW APPLICATION ENTERED
Wednesday, November 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Thursday, February 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 23, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, November 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 23, 2020USE AMENDMENT FILED
Saturday, November 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 1, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 2, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 14, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 14, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 14, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 14, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 14, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED